BEAM in the 13F filings
Beam Therapeutics Inc · CUSIP 07373V105
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 6 Aug 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 3 listed it in both
- Shares listed
- 40,592,725
- combined, among listed positions
- Reported value
- $1.4bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 17 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -575,493.
Managers listing BEAM in Q2 2026
24 of 24 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 3,415,239 shares now+702,009
- Marshall Wace LLPexisting position · 478,980 shares now+339,739
- Arrowstreet Capital LPnew position · 296,294 shares now+296,294
- Two Sigma Investments LPexisting position · 1,388,227 shares now+177,374
- Fidelity (FMR LLC)existing position · 12,609,002 shares now+156,803
Reductions
- ARK Investment Management LLCexisting position · 10,234,862 shares now-1,898,571
- Man Group PLCexisting position · 129,820 shares now-102,174
- Baillie Gifford & Coexisting position · 314,228 shares now-71,663
- Renaissance Technologies LLCexisting position · 445,000 shares now-68,578
- Susquehanna International Group LLPexisting position · 134,679 shares now-43,712
New positions and exits
New (6)
Exited (1)
- Citadel Advisors LLCwas $13m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2020 | 1 | $3.1m | n.a. | n.a. |
| Q4 2020 | 4 | $705m | n.a. | n.a. |
| Q1 2021 | 6 | $1.1bn | n.a. | n.a. |
| Q2 2021 | 6 | $2.1bn | n.a. | n.a. |
| Q3 2021 | 5 | $769m | n.a. | n.a. |
| Q4 2021 | 3 | $818m | n.a. | n.a. |
| Q1 2022 | 4 | $620m | n.a. | n.a. |
| Q2 2022 | 4 | $457m | n.a. | n.a. |
| Q3 2022 | 5 | $610m | n.a. | n.a. |
| Q4 2022 | 4 | $481m | n.a. | n.a. |
| Q1 2023 | 4 | $397m | n.a. | n.a. |
| Q2 2023 | 3 | $394m | n.a. | n.a. |
| Q3 2023 | 4 | $351m | n.a. | n.a. |
| Q4 2023 | 4 | $389m | 2 | 3 |
| Q1 2024 | 4 | $446m | 2 | 3 |
| Q2 2024 | 3 | $379m | 1 | 3 |
| Q3 2024 | 3 | $370m | 1 | 2 |
| Q4 2024 | 4 | $394m | 3 | 1 |
| Q1 2025 | 5 | $419m | 4 | 1 |
| Q2 2025 | 5 | $358m | 4 | 1 |
| Q3 2025 | 7 | $571m | 5 | 2 |
| Q4 2025 | 6 | $692m | 18 | 8 |
| Q1 2026 | 3 | $540m | 14 | 13 |
| Q2 2026 | 3 | $713m | 17 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BEAM and GILD →BEAM and AMGN →BEAM and ARGX →Choose a stock to compare with BEAM →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BEAM, latest filings →Back to the 13F Explorer →